These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 30930179)
1. Repeated treatments with the D Park HJ; Zhao TT; Park KH; Lee MK Behav Brain Res; 2019 Jul; 367():166-175. PubMed ID: 30930179 [TBL] [Abstract][Full Text] [Related]
2. Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models. Park HJ; Zhao TT; Lee KS; Lee SH; Shin KS; Park KH; Choi HS; Lee MK Neurochem Int; 2015; 83-84():19-27. PubMed ID: 25747493 [TBL] [Abstract][Full Text] [Related]
4. L-DOPA modulates cell viability through the ERK-c-Jun system in PC12 and dopaminergic neuronal cells. Park KH; Shin KS; Zhao TT; Park HJ; Lee KE; Lee MK Neuropharmacology; 2016 Feb; 101():87-97. PubMed ID: 26363191 [TBL] [Abstract][Full Text] [Related]
5. The roles of cyclic AMP-ERK-Bad signaling pathways on 6-hydroxydopamine-induced cell survival and death in PC12 cells. Park HJ; Park KH; Shin KS; Lee MK Toxicol In Vitro; 2013 Dec; 27(8):2233-41. PubMed ID: 24055892 [TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra. Huang KX; Bergstrom DA; Ruskin DN; Walters JR Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877 [TBL] [Abstract][Full Text] [Related]
7. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity. Paul ML; Currie RW; Robertson HA Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output. Huang KX; Walters JR J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456 [TBL] [Abstract][Full Text] [Related]
10. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons. Frau L; Morelli M; Simola N Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830 [TBL] [Abstract][Full Text] [Related]
11. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats. Rodríguez-Puertas R; Herrera-Marschitz M; Koistinaho J; Hökfelt T Neuroscience; 1999 Mar; 89(3):781-97. PubMed ID: 10199613 [TBL] [Abstract][Full Text] [Related]
12. Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats. Cai G; Zhen X; Uryu K; Friedman E J Neurosci; 2000 Mar; 20(5):1849-57. PubMed ID: 10684886 [TBL] [Abstract][Full Text] [Related]
13. Changes in apical dendritic structure correlate with sustained ERK1/2 phosphorylation in medial prefrontal cortex of a rat model of dopamine D1 receptor agonist sensitization. Papadeas ST; Halloran C; McCown TJ; Breese GR; Blake BL J Comp Neurol; 2008 Nov; 511(2):271-85. PubMed ID: 18785628 [TBL] [Abstract][Full Text] [Related]
14. Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits. Oh JD; Vaughan CL; Chase TN Brain Res; 1999 Mar; 821(2):433-42. PubMed ID: 10064831 [TBL] [Abstract][Full Text] [Related]
15. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum. Hu XT; Brooderson RJ; White FJ Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592 [TBL] [Abstract][Full Text] [Related]
16. Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease. Mishra A; Singh S; Tiwari V; Bano S; Shukla S Behav Brain Res; 2020 Jan; 378():112304. PubMed ID: 31626851 [TBL] [Abstract][Full Text] [Related]
17. Neonatal 6-hydroxydopamine and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats. Gong L; Kostrzewa RM; Li C J Neurochem; 1994 Oct; 63(4):1282-90. PubMed ID: 7931280 [TBL] [Abstract][Full Text] [Related]
18. Dynorphin modulates dopamine D1-receptor mediated turning behavior in 6-hydroxydopamine-lesioned rats. van de Witte SV; Groenewegen HJ; Drukarch B; Voorn P Neurosci Lett; 2000 Aug; 290(1):37-40. PubMed ID: 10925169 [TBL] [Abstract][Full Text] [Related]
19. Intracellularly recorded response of rat striatal neurons in vitro to fenoldopam and SKF 38393 following lesions of midbrain dopamine cells. Twery MJ; Thompson LA; Walters JR Synapse; 1994 Sep; 18(1):67-78. PubMed ID: 7825125 [TBL] [Abstract][Full Text] [Related]
20. Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats. Casas M; Prat G; Rubio A; Barbanoj M; Jané F Eur J Pharmacol; 2000 May; 396(2-3):93-9. PubMed ID: 10822061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]